ArticleJournal of immunology (Baltimore, Md. : 1950)2019

LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8

Aeryon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.